Published in Vaccine Weekly, December 21st, 2011
To improve R&D productivity and curtail expenses, pharmaceutical companies are downsizing and strategically outsourcing operations, in-licensing from small innovators, investing in IT automation, and moving research into lower-cost emerging regions. The top emerging markets for pharmaceutical companies include Eastern Europe, Latin America, and Asia.
An R&D leader for many years, Pfizer was the top pharmaceutical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.